This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Hepatitis is a serious and potentially life-threatening virus that affects the liver. It can be caused by a variety of viruses, including hepatitis A, B, C, D and E. Treatment for hepatitis depends on the type of virus causing the infection. Hepatitis A is the least serious form of hepatitis and can usually be treated with rest and supportive care. Vaccination is available to prevent infection with the virus. Vaccines are usually given in two doses and are most effective when given before exposure to the virus. Hepatitis B is a more serious form of hepatitis and is usually treated with antiviral medications. These medications can help reduce the symptoms of the infection and are often used in combination with other medications. Vaccines are available to prevent infection with the virus. Vaccines are usually given in three doses and are most effective when given before exposure to the virus. Hepatitis C is the most serious form of hepatitis and is usually treated with antiviral medications. These medications can help reduce the symptoms of the infection and are often used in combination with other medications. Vaccines are not available for hepatitis C.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States